US Patent 7691823 RIP140 regulation of glucose transport
Patent 7691823 was granted and assigned to University of Massachusetts on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+309 characters)
Article
Patent abstract
Inhibition of RIP140 increases glucose transport. Compounds that inhibit RIP140 expression or activity are useful for treating disorders associated with aberrant glucose transport (e.g., diabetes), treating obesity, increasing metabolism (e.g., fatty acid metabolism), and increasing brown fat.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07691823 RIP140 regulation of glucose transport US Patent 7691823 RIP140 regulation of glucose transport
Infobox
Patent Number
0769182300
Patent Number
769182300
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076918230
Date of Patent
April 6, 2010
0Patent Application Number
110756460
Date Filed
March 7, 2005
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076918230
Date of Patent
April 6, 2010
0Patent Application Number
110756460
Date Filed
March 7, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07691823 RIP140 regulation of glucose transport
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07691823
Date of patent
April 6, 2010
Patent application number
11075646
Date Filed
March 7, 2005
Patent primary examiner
Find more entities like US Patent 7691823 RIP140 regulation of glucose transport
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
